HYBRID EVENT: You can participate in person at Singapore or Virtually from your home or work.
2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Translational and Clinical Cancer Research
Translational and Clinical Cancer Research
- Liquid Biopsies and Biomarker Discovery
- Role of Artificial Intelligence in Cancer Diagnostics
- Innovative Clinical Trial Designs in Oncology
- Real-World Data and Evidence in Cancer Treatment
Translational and clinical cancer research plays a vital role in turning laboratory discoveries into real-world medical treatments. This field focuses on applying insights from basic science to develop novel therapies, aiming to enhance the quality of patient care. It encompasses the exploration of cancer mechanisms, the identification of potential biomarkers, and the testing of treatments through clinical trials. By bridging the gap between research and patient care, this approach fosters the creation of targeted therapies that are both innovative and personalized. As a result, translational and clinical research accelerates the delivery of cutting-edge cancer treatments to patients in need.
Committee Members
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Thomas J Webster
Brown University, United States CIOC 2026 Speakers
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Rihab Melliti
Aix en Provence General Hospital, FranceSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : Anti-cancer nanomedicine in humans: A review and future directions
Thomas J Webster, Brown University, United States
Title : Diagnosis and treatment of primary cardiac lymphoma in an immunocompetent 27-year-old man
Moataz Taha Mahmoud Abdelsalam, Madinah Cardiac Center, Saudi Arabia
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Personalized and Precision Medicine (PPM) through the view of biodesign-inspired translational research: An option for clinical oncologists, caregivers, and consumers to realize the potential of genomics-informed care to secure human biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation